Related Experiment Video
Updated: Jun 17, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Hypertension and hemostatic/fibrinolytic balance disorders
1Department of Internal Medicine, Istanbul Education and Research Hospital, Istanbul, Turkey.
Hypertension is linked to impaired fibrinolysis, with elevated levels of plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) observed. These fibrinolytic disturbances may precede cardiovascular events in hypertensive patients.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Hypertension Research
Background:
- Hypertension is a primary risk factor for cardiovascular disease.
- Fibrinolytic balance and endothelial function are crucial in cardiovascular health.
- Investigating the link between hypertension and fibrinolysis is essential for understanding disease progression.
Purpose of the Study:
- To evaluate the impact of hypertension on fibrinolytic balance.
- To measure plasma levels of key fibrinolytic markers and fibrinogen in hypertensive patients.
- To assess the relationship between hypertension and endothelial function indicators.
Main Methods:
- Study included 22 essential hypertensive (EH), 22 white coat hypertensive (WCH), 22 renovascular hypertensive (RH), and 22 normotensive control subjects.
- Plasma levels of plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator antigen (tPA), and tPA/PAI-1 complex were measured.
- Enzyme-linked immunosorbent assays (ELISAs) were utilized for plasma level measurements.
Main Results:
- Hypertensive groups (EH, WCH, RH) showed increased plasma levels of PAI-1, tPA, tPA/PAI-1 complex, and fibrinogen compared to controls.
- No significant differences in systolic or diastolic blood pressure were found between EH and RH groups.
- No fibrinolytic parameter was directly associated with blood pressure levels within the hypertensive subjects.
Conclusions:
- Fibrinolytic markers (PAI-1, tPA, tPA/PAI-1 complex) are independently associated with hypertension development.
- Disturbances in fibrinolysis are suggested to precede cardiovascular events.
- Hypertension may be linked to impaired fibrinolytic activity, highlighting potential therapeutic targets.
More Related Videos
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology